Target intelligence / Profile preview

Bacterial, viral, and fungal surface antigen

Molecular classification
Surface protein, Polysaccharide, Glycoprotein, Lipopolysaccharide, Lipoprotein
01

Overview

Bacterial, viral, and fungal surface antigens are a diverse group of molecules, including proteins, polysaccharides, and lipids, located on the exterior of pathogenic microorganisms. These molecules are essential for the pathogen's life cycle, mediating critical processes such as host cell adhesion, entry, and evasion of the host immune response (Baron S, Medical Microbiology, 1996). As the most accessible components of a pathogen, they serve as the primary targets for the host's adaptive immune system and are the foundation for the design of most vaccines and therapeutic monoclonal antibodies (Janeway et al., Immunobiology, 2001). For instance, viral envelope proteins like the SARS-CoV-2 spike protein or bacterial capsular polysaccharides are targeted to prevent infection or facilitate pathogen clearance (NIH, 2023). Therapeutic intervention against these antigens often involves neutralization, where drug binding prevents the pathogen from interacting with host receptors, or opsonization, which marks the pathogen for destruction by phagocytes. However, the high degree of diversity and the potential for rapid antigenic evolution, such as antigenic drift in viruses, pose significant challenges for long-term therapeutic efficacy (Nature Reviews Microbiology, 2018).

Other names
Microbial surface antigensPathogen surface moleculesSurface markersExoantigensPathogen-associated molecular patterns (PAMPs)
02

Mechanism of action

Binding to pathogen surface components to neutralize infectivity, inhibit cell wall synthesis, or promote immune-mediated clearance via opsonization and complement activation.

03

Biological functions

Cell adhesionHost cell invasionImmune evasionStructural integrityPathogen recognition
04

Disease associations

Bacterial infectionViral infectionFungal infectionSepsis
05

Safety considerations

AnaphylaxisMolecular mimicry leading to autoimmunityAntigenic drift and shiftInfusion-related reactions
06

Interacting drugs

Palivizumab

8 more in the full profile.

07

Biomarkers

Serum antigen levels (e.g., HBsAg, Galactomannan)Antibody titers (IgG/IgM)Pathogen DNA/RNA load

Beyond the preview

Go deeper on Bacterial, viral, and fungal surface antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial, viral, and fungal surface antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call